 | • レポートコード：20QY06-04969 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、眼科用医薬品のグローバル市場について種類別（網膜障害薬、アレルギー薬、炎症薬、感染症薬、緑内障薬、ドライアイ薬、その他点眼薬）、用途別（緑内障、ドライアイ症候群、網膜疾患、その他適応症（眼））、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・眼科用医薬品市場の概要 ・世界の主要地域別眼科用医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の眼科用医薬品市場規模2015-2026：種類別（網膜障害薬、アレルギー薬、炎症薬、感染症薬、緑内障薬、ドライアイ薬、その他点眼薬） ・世界の眼科用医薬品市場規模2015-2026：用途別（緑内障、ドライアイ症候群、網膜疾患、その他適応症（眼）） ・眼科用医薬品の北米市場規模2015-2020 ・眼科用医薬品のヨーロッパ市場規模2015-2020 ・眼科用医薬品の中国市場規模2015-2020 ・眼科用医薬品の日本市場規模2015-2020 ・眼科用医薬品の東南アジア市場規模2015-2020 ・眼科用医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis、Allergan、Roche、Valeant、Regeneron、Santen、Bayer、Pfizer、Senju、Akorn） ・眼科用医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・眼科用医薬品の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Pharma Ophthalmic Market
The global Pharma Ophthalmic market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Pharma Ophthalmic Scope and Market Size
The global Pharma Ophthalmic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharma Ophthalmic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pharma Ophthalmic market is segmented into
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
Segment by Application, the Pharma Ophthalmic market is segmented into
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
The Pharma Ophthalmic market is analysed and market size information is provided by regions (countries). Segment by Application, the Pharma Ophthalmic market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pharma Ophthalmic Market Share Analysis
Pharma Ophthalmic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pharma Ophthalmic business, the date to enter into the Pharma Ophthalmic market, Pharma Ophthalmic product introduction, recent developments, etc.
The major vendors covered:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
Table of Contents
1 Pharma Ophthalmic Market Overview
1.1 Pharma Ophthalmic Product Scope
1.2 Pharma Ophthalmic Segment by Type
1.2.1 Global Pharma Ophthalmic Sales by Type (2020-2026)
1.2.2 Retinal disorders drugs
1.2.3 Allergic, inflammatory and infective drugs
1.2.4 Glaucoma drugs
1.2.5 Dry eye drugs
1.2.6 Other ophthalmic drugs
1.3 Pharma Ophthalmic Segment by Application
1.3.1 Global Pharma Ophthalmic Sales Comparison by Application (2020-2026)
1.3.2 Glaucoma
1.3.3 Dry eye syndrome
1.3.4 Retinal diseases
1.3.5 Other ophthalmic indications
1.4 Pharma Ophthalmic Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pharma Ophthalmic Sales Growth Rate (2015-2026)
1.4.2 Global Pharma Ophthalmic Revenue and Growth Rate (2015-2026)
1.4.3 Global Pharma Ophthalmic Price Trends (2015-2026)
2 Pharma Ophthalmic Estimate and Forecast by Region
2.1 Global Pharma Ophthalmic Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pharma Ophthalmic Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pharma Ophthalmic Sales Market Share by Region (2015-2020)
2.2.2 Global Pharma Ophthalmic Revenue Market Share by Region (2015-2020)
2.3 Global Pharma Ophthalmic Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pharma Ophthalmic Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pharma Ophthalmic Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pharma Ophthalmic Estimates and Projections (2015-2026)
2.4.2 Europe Pharma Ophthalmic Estimates and Projections (2015-2026)
2.4.3 China Pharma Ophthalmic Estimates and Projections (2015-2026)
2.4.4 Japan Pharma Ophthalmic Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pharma Ophthalmic Estimates and Projections (2015-2026)
2.4.6 India Pharma Ophthalmic Estimates and Projections (2015-2026)
3 Global Pharma Ophthalmic Competition Landscape by Players
3.1 Global Top Pharma Ophthalmic Players by Sales (2015-2020)
3.2 Global Top Pharma Ophthalmic Players by Revenue (2015-2020)
3.3 Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma Ophthalmic as of 2019)
3.4 Global Pharma Ophthalmic Average Price by Company (2015-2020)
3.5 Manufacturers Pharma Ophthalmic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pharma Ophthalmic Players (Opinion Leaders)
4 Global Pharma Ophthalmic Market Size by Type
4.1 Global Pharma Ophthalmic Historic Market Review by Type (2015-2020)
4.1.1 Global Pharma Ophthalmic Sales Market Share by Type (2015-2020)
4.1.2 Global Pharma Ophthalmic Revenue Market Share by Type (2015-2020)
4.1.3 Global Pharma Ophthalmic Price by Type (2014-2020)
4.2 Global Pharma Ophthalmic Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pharma Ophthalmic Sales Forecast by Type (2021-2026)
4.2.2 Global Pharma Ophthalmic Revenue Forecast by Type (2021-2026)
4.2.3 Global Pharma Ophthalmic Price Forecast by Type (2021-2026)
5 Global Pharma Ophthalmic Market Size by Application
5.1 Global Pharma Ophthalmic Historic Market Review by Application (2015-2020)
5.1.1 Global Pharma Ophthalmic Sales Market Share by Application (2015-2020)
5.1.2 Global Pharma Ophthalmic Revenue Market Share by Application (2015-2020)
5.1.3 Global Pharma Ophthalmic Price by Application (2015-2020)
5.2 Global Pharma Ophthalmic Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pharma Ophthalmic Sales Forecast by Application (2021-2026)
5.2.2 Global Pharma Ophthalmic Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharma Ophthalmic Price Forecast by Application (2021-2026)
3 North America Pharma Ophthalmic Market Facts & Figures
3.2 North America Pharma Ophthalmic Sales Market Share by Company (2015-2020)
3.3 North America Pharma Ophthalmic Sales Market Share by Type (2015-2020)
3.4 North America Pharma Ophthalmic Sales Market Share by Application (2015-2020)
4 Europe Pharma Ophthalmic Market Facts & Figures
4.2 Europe Pharma Ophthalmic Sales Market Share by Company (2015-2020)
4.3 Europe Pharma Ophthalmic Sales Market Share by Type (2015-2020)
4.4 Europe Pharma Ophthalmic Sales Market Share by Application (2015-2020)
5 China Pharma Ophthalmic Market Facts & Figures
5.2 China Pharma Ophthalmic Sales Market Share by Company (2015-2020)
5.3 China Pharma Ophthalmic Sales Market Share by Type (2015-2020)
5.4 China Pharma Ophthalmic Sales Market Share by Application (2015-2020)
6 Japan Pharma Ophthalmic Market Facts & Figures
6.2 Japan Pharma Ophthalmic Sales Market Share by Company (2015-2020)
6.3 Japan Pharma Ophthalmic Sales Market Share by Type (2015-2020)
6.4 Japan Pharma Ophthalmic Sales Market Share by Application (2015-2020)
7 Southeast Asia Pharma Ophthalmic Market Facts & Figures
7.2 Southeast Asia Pharma Ophthalmic Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pharma Ophthalmic Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pharma Ophthalmic Sales Market Share by Application (2015-2020)
8 India Pharma Ophthalmic Market Facts & Figures
8.2 India Pharma Ophthalmic Sales Market Share by Company (2015-2020)
8.3 India Pharma Ophthalmic Sales Market Share by Type (2015-2020)
8.4 India Pharma Ophthalmic Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pharma Ophthalmic Business
12.1 Novartis
12.1.1 Novartis Pharma Ophthalmic Corporation Information
12.1.2 Novartis Pharma Ophthalmic Business Overview and Total Revenue
12.1.3 Novartis Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Pharma Ophthalmic Products Offered
12.1.5 Novartis Recent Development
12.2 Allergan
12.2.1 Allergan Pharma Ophthalmic Corporation Information
12.2.2 Allergan Pharma Ophthalmic Business Overview and Total Revenue
12.2.3 Allergan Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Pharma Ophthalmic Products Offered
12.2.5 Allergan Recent Development
12.3 Roche
12.3.1 Roche Pharma Ophthalmic Corporation Information
12.3.2 Roche Pharma Ophthalmic Business Overview and Total Revenue
12.3.3 Roche Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Pharma Ophthalmic Products Offered
12.3.5 Roche Recent Development
12.4 Valeant
12.4.1 Valeant Pharma Ophthalmic Corporation Information
12.4.2 Valeant Pharma Ophthalmic Business Overview and Total Revenue
12.4.3 Valeant Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Valeant Pharma Ophthalmic Products Offered
12.4.5 Valeant Recent Development
12.5 Regeneron
12.5.1 Regeneron Pharma Ophthalmic Corporation Information
12.5.2 Regeneron Pharma Ophthalmic Business Overview and Total Revenue
12.5.3 Regeneron Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Regeneron Pharma Ophthalmic Products Offered
12.5.5 Regeneron Recent Development
12.6 Santen
12.6.1 Santen Pharma Ophthalmic Corporation Information
12.6.2 Santen Pharma Ophthalmic Business Overview and Total Revenue
12.6.3 Santen Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Santen Pharma Ophthalmic Products Offered
12.6.5 Santen Recent Development
12.7 Bayer
12.7.1 Bayer Pharma Ophthalmic Corporation Information
12.7.2 Bayer Pharma Ophthalmic Business Overview and Total Revenue
12.7.3 Bayer Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bayer Pharma Ophthalmic Products Offered
12.7.5 Bayer Recent Development
12.8 Pfizer
12.8.1 Pfizer Pharma Ophthalmic Corporation Information
12.8.2 Pfizer Pharma Ophthalmic Business Overview and Total Revenue
12.8.3 Pfizer Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Pharma Ophthalmic Products Offered
12.8.5 Pfizer Recent Development
12.9 Senju
12.9.1 Senju Pharma Ophthalmic Corporation Information
12.9.2 Senju Pharma Ophthalmic Business Overview and Total Revenue
12.9.3 Senju Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Senju Pharma Ophthalmic Products Offered
12.9.5 Senju Recent Development
12.10 Akorn
12.10.1 Akorn Pharma Ophthalmic Corporation Information
12.10.2 Akorn Pharma Ophthalmic Business Overview and Total Revenue
12.10.3 Akorn Pharma Ophthalmic Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Akorn Pharma Ophthalmic Products Offered
12.10.5 Akorn Recent Development
13 Pharma Ophthalmic Manufacturing Cost Analysis
13.1 Pharma Ophthalmic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pharma Ophthalmic
13.4 Pharma Ophthalmic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pharma Ophthalmic Distributors List
14.3 Pharma Ophthalmic Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pharma Ophthalmic Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Pharma Ophthalmic Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Pharma Ophthalmic Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pharma Ophthalmic Sales (K Pcs) by Region (2015-2020)
Table 5. Global Pharma Ophthalmic Sales Market Share by Region (2015-2020)
Table 6. Global Pharma Ophthalmic Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pharma Ophthalmic Revenue Share by Region (2015-2020)
Table 8. Global Pharma Ophthalmic Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Pharma Ophthalmic Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pharma Ophthalmic Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pharma Ophthalmic Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pharma Ophthalmic (K Pcs) of Key Companies (2015-2020)
Table 13. Global Pharma Ophthalmic Sales Share by Company (2015-2020)
Table 14. Global Pharma Ophthalmic Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pharma Ophthalmic Revenue Share by Company (2015-2020)
Table 16. Global Pharma Ophthalmic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma Ophthalmic as of 2019)
Table 17. Global Pharma Ophthalmic Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Pharma Ophthalmic Manufacturing Sites and Area Served
Table 19. Manufacturers Pharma Ophthalmic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pharma Ophthalmic Players
Table 22. Global Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 23. Global Pharma Ophthalmic Sales Share by Type (2015-2020)
Table 24. Global Pharma Ophthalmic Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pharma Ophthalmic Price (K Pcs) by Type (2015-2020)
Table 26. Global Pharma Ophthalmic Sales Share by Type (2021-2026)
Table 27. Global Pharma Ophthalmic Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pharma Ophthalmic Revenue Share by Type (2021-2026)
Table 29. Global Pharma Ophthalmic Price (K Pcs) by Type (2021-2026)
Table 30. Global Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 31. Global Pharma Ophthalmic Sales Share by Application (2015-2020)
Table 32. Global Pharma Ophthalmic Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pharma Ophthalmic Price (K Pcs) by Application (2015-2020)
Table 34. Global Pharma Ophthalmic Sales (K Pcs) by Application (2021-2026)
Table 35. Global Pharma Ophthalmic Sales Share by Application (2021-2026)
Table 36. Global Pharma Ophthalmic Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pharma Ophthalmic Revenue Share by Application (2021-2026)
Table 38. Global Pharma Ophthalmic Price (K Pcs) by Application (2021-2026)
Table 39. United States Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 40. United States Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 41. United States Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 42. United States Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 43. United States Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 44. United States Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 45. Europe Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 47. Europe Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 49. Europe Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 51. China Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 52. China Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 53. China Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 54. China Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 55. China Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 56. China Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 57. Japan Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 59. Japan Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 61. Japan Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 69. India Pharma Ophthalmic Sales (K Pcs) by Company (2015-2020)
Table 70. India Pharma Ophthalmic Sales Market Share by Company (2015-2020)
Table 71. India Pharma Ophthalmic Sales (K Pcs) by Type (2015-2020)
Table 72. India Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 73. India Pharma Ophthalmic Sales (K Pcs) by Application (2015-2020)
Table 74. India Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Novartis Pharma Ophthalmic Product
Table 79. Novartis Recent Development
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Allergan Pharma Ophthalmic Product
Table 84. Allergan Recent Development
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Roche Pharma Ophthalmic Product
Table 89. Roche Recent Development
Table 90. Valeant Corporation Information
Table 91. Valeant Description and Business Overview
Table 92. Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Valeant Pharma Ophthalmic Product
Table 94. Valeant Recent Development
Table 95. Regeneron Corporation Information
Table 96. Regeneron Description and Business Overview
Table 97. Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Regeneron Pharma Ophthalmic Product
Table 99. Regeneron Recent Development
Table 100. Santen Corporation Information
Table 101. Santen Description and Business Overview
Table 102. Santen Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Santen Pharma Ophthalmic Product
Table 104. Santen Recent Development
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Bayer Pharma Ophthalmic Product
Table 109. Bayer Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Pfizer Description and Business Overview
Table 113. Pfizer Pharma Ophthalmic Product
Table 114. Pfizer Recent Development
Table 115. Senju Corporation Information
Table 116. Senju Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Senju Description and Business Overview
Table 118. Senju Pharma Ophthalmic Product
Table 119. Senju Recent Development
Table 120. Akorn Corporation Information
Table 121. Akorn Description and Business Overview
Table 122. Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Akorn Pharma Ophthalmic Product
Table 124. Akorn Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Pharma Ophthalmic Distributors List
Table 128. Pharma Ophthalmic Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Ophthalmic Product Picture
Figure 2. Global Pharma Ophthalmic Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pharma Ophthalmic Market Share by Application in 2020 & 2026
Figure 6. Glaucoma Examples
Figure 7. Dry eye syndrome Examples
Figure 8. Retinal diseases Examples
Figure 9. Other ophthalmic indications Examples
Figure 10. Global Pharma Ophthalmic Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Pharma Ophthalmic Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Pharma Ophthalmic Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Pharma Ophthalmic Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Pharma Ophthalmic Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Pharma Ophthalmic Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Pharma Ophthalmic Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Pharma Ophthalmic Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Pharma Ophthalmic Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Pharma Ophthalmic Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Pharma Ophthalmic Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Pharma Ophthalmic Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Pharma Ophthalmic Players Market Share by Revenue in Pharma Ophthalmic 2015 & 2019
Figure 28. Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Pharma Ophthalmic Revenue Share by Type (2015-2020)
Figure 30. Global Pharma Ophthalmic Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Pharma Ophthalmic Revenue Share by Application (2015-2020)
Figure 32. Global Pharma Ophthalmic Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 34. United States Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 35. Europe Pharma Ophthalmic Sales Market Share by Company in 2019
Figure 36. Europe Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 37. Europe Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 38. China Pharma Ophthalmic Sales Market Share by Company in 2019
Figure 39. China Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 40. China Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 41. Japan Pharma Ophthalmic Sales Market Share by Company in 2019
Figure 42. Japan Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 43. Japan Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 44. Southeast Asia Pharma Ophthalmic Sales Market Share by Company in 2019
Figure 45. Southeast Asia Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 46. Southeast Asia Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 47. India Pharma Ophthalmic Sales Market Share by Company in 2019
Figure 48. India Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 49. India Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Senju Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Pharma Ophthalmic
Figure 62. Manufacturing Process Analysis of Pharma Ophthalmic
Figure 63. Pharma Ophthalmic Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
抗感染性眼炎剤の世界市場レポート2020 A recently published report by QY Research titled Global Anti-infective Ophthalmic Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…- 眼科用器具の世界市場レポート2020 Ophthalmology is a branch of medicine and surgery that deals with the anatomy, physiology and diseases of the eyeball and orbit. An ophthalmologist is a specialist in medical and surgical eye disease. Market Analysis and Insights: Global Ophthalmic Devices Market The global Ophthalmic Devices market…
- 眼科用器具台の世界市場レポート2020 Ophthalmic Instrument Tables are full line of tables designed to save time and space while providing added efficiency to your practice. Market Analysis and Insights: Global Ophthalmic Instrument Tables Market The global Ophthalmic Instrument Tables market was valued at US$ xx million in 2019 and wil…
- 眼科用ガイドワイヤーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Guidewire market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmic Guidewire mar…
- 眼科用粘弾性デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Viscoelastic Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmic Vis…